PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the key takeaways from the ASCO 2025 Annual ...

We often talk about how Patient Services is for everyone, not just people living with the disease. What kind of people do you hear from, and what can Patient Services do for them? Karina: I am always ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Two out of every five Americans will be diagnosed with cancer in their lifetime. These are sobering statistics that remind us why investment in cancer research is so critically important for saving ...

Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...

The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called PNET or PanNET. “I am delighted that patients with pancreatic ...

This week, I had the privilege of visiting Capitol Hill to advocate for federal funding for #pancreaticcancer research with PanCAN President & CEO, Julie Fleshman. In conversations with lawmakers, I ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights about the latest news ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

While pancreatic cancer remains one of the toughest cancers to treat and is predicted to become the second-leading cause of cancer-related death in the U.S. before 2030, research and treatment ...

A device already approved to treat several other types of cancer has shown positive results for a subset of patients with pancreatic cancer. In a Phase III clinical trial, a therapy known as Tumor ...

Read this story in English El Mes Nacional de la Herencia Hispana (del 15 de septiembre al 15 de octubre), es una oportunidad especial para hacer un reconocimiento y celebrar a generaciones de ...